Jim Cramer in a recent program on CNBC expressed his frustration over the recent market selloff following tariff ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Johnson & Johnson's spin-off of Kenvue has created two resilient defensive stocks in the healthcare sector, ideal for ...

Johnson & Johnson (NYSE:JNJ) recently announced the appointment of Jessica Moore as the Group Chief Financial Officer for ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from ...

This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For the current quarter, Johnson & Johnson is expected ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Johnson & Johnson (JNJ – Research Report), ...

Guggenheim reiterated their neutral rating on shares of Johnson & Johnson (NYSE:JNJ – Free Report) in a research note issued to investors on Monday morning,Benzinga reports. JNJ has been the topic of ...

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...